U.S. markets open in 15 minutes

MediPharm Labs Corp. (MLZ.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.3082-0.0130 (-4.05%)
As of 8:14AM CEST. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3212
Open0.3082
Bid0.3084 x 0
Ask0.3244 x 0
Day's Range0.3082 - 0.3082
52 Week Range0.2616 - 0.8900
Volume15
Avg. Volume15,331
Market Cap80.86M
Beta (5Y Monthly)0.74
PE Ratio (TTM)N/A
EPS (TTM)-0.2760
Earnings DateAug 16, 2021 - Aug 20, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • MediPharm Labs Enters Research Agreement with McMaster University to Develop Drugs Containing Cannabis Candidates
      GlobeNewswire

      MediPharm Labs Enters Research Agreement with McMaster University to Develop Drugs Containing Cannabis Candidates

      MediPharm Labs’ Cannabis Drug Licence and expertise qualifies and positions the Company to supply clinical trial material, assist in investigation protocol and provide regulatory support for multiple trialsThree initial proposed clinical trials will evaluate the effectiveness of proprietary THC and CBD drug candidates for multiple indications including Pain, Insomnia associated with Major Depression, and Uremic Pruritus. BARRIE, Ontario, June 21, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TS

    • MediPharm Labs Announces Voting Results From the 2021 Annual Meeting of Shareholders
      GlobeNewswire

      MediPharm Labs Announces Voting Results From the 2021 Annual Meeting of Shareholders

      BARRIE, Ontario, June 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced the results of matters voted on at its annual meeting of holders of common shares held on Wednesday, June 9, 2021 (the “Meeting”). The voting results for each of the matters presented at the Meeting are outli

    • MediPharm Labs Extends Strategic Partnership with ADREXpharma and continues to Build its Presence in Germany
      GlobeNewswire

      MediPharm Labs Extends Strategic Partnership with ADREXpharma and continues to Build its Presence in Germany

      MediPharm and ADREXpharma continue to lead the way addressing rising patient demand in the burgeoning German Medical Cannabis Market that saw sales increase 34% last year 128,000 active patients at end of 2020; German patients spent an average of $500EUR per month, finished products and extract sales continue to gain market share MediPharm and ADREXpharma on track to deliver subsequent shipments to Germany in Q2 2021, completed first shipments in Q1 2021 ADREXpharma is Germany’s largest independ